Sandra A. Radema

5.4k total citations
37 papers, 1.1k citations indexed

About

Sandra A. Radema is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Sandra A. Radema has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 11 papers in Immunology and 10 papers in Genetics. Recurrent topics in Sandra A. Radema's work include Cancer Treatment and Pharmacology (13 papers), Inflammatory Bowel Disease (10 papers) and Microscopic Colitis (6 papers). Sandra A. Radema is often cited by papers focused on Cancer Treatment and Pharmacology (13 papers), Inflammatory Bowel Disease (10 papers) and Microscopic Colitis (6 papers). Sandra A. Radema collaborates with scholars based in Netherlands, United States and Austria. Sandra A. Radema's co-authors include Sander J. H. van Deventer, Anthony Cerami, Els O. Witteveen, Emile E. Voest, Johannes H.W. de Wilt, Rob H.A. Verhoeven, Irıs D. Nagtegaal, Niek Hugen, V.E.P.P. Lemmens and Jan H.M. Schellens and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Gut.

In The Last Decade

Sandra A. Radema

35 papers receiving 1.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Sandra A. Radema 505 290 244 160 149 37 1.1k
Efstathios Antoniou 515 1.0× 356 1.2× 422 1.7× 139 0.9× 183 1.2× 83 1.4k
Christian Klemann 437 0.9× 199 0.7× 257 1.1× 366 2.3× 135 0.9× 48 1.3k
Delphine Bonnet 241 0.5× 183 0.6× 250 1.0× 124 0.8× 115 0.8× 53 1.0k
Victoria P. Tan 449 0.9× 294 1.0× 426 1.7× 76 0.5× 133 0.9× 29 1.2k
Mariana Kiomy Osako 253 0.5× 171 0.6× 421 1.7× 159 1.0× 106 0.7× 40 1.2k
K Orita 354 0.7× 344 1.2× 319 1.3× 164 1.0× 183 1.2× 122 1.2k
Beat Künzli 453 0.9× 336 1.2× 543 2.2× 304 1.9× 166 1.1× 39 1.6k
Ayşe Dursun 274 0.5× 497 1.7× 228 0.9× 60 0.4× 214 1.4× 82 1.2k
Yifeng Zou 610 1.2× 261 0.9× 408 1.7× 188 1.2× 176 1.2× 67 1.2k
Jee Hyun Kim 485 1.0× 136 0.5× 406 1.7× 171 1.1× 192 1.3× 36 1.3k

Countries citing papers authored by Sandra A. Radema

Since Specialization
Citations

This map shows the geographic impact of Sandra A. Radema's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra A. Radema with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra A. Radema more than expected).

Fields of papers citing papers by Sandra A. Radema

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra A. Radema. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra A. Radema. The network helps show where Sandra A. Radema may publish in the future.

Co-authorship network of co-authors of Sandra A. Radema

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra A. Radema. A scholar is included among the top collaborators of Sandra A. Radema based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra A. Radema. Sandra A. Radema is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Doorduin, Jonne, Monique A. H. Steegers, Ewald M. Bronkhorst, et al.. (2019). Simple surface EMG recording as a noninvasive screening method for the detection of acute oxaliplatin-induced neurotoxicity: a feasibility pilot study. Neuroscience Letters. 699. 184–188. 5 indexed citations
3.
Geenen, Erwin J. M. van, B.M. van der Kolk, Irıs D. Nagtegaal, et al.. (2019). Improving preoperative detection of synchronous liver metastases in pancreatic cancer with combined contrast-enhanced and diffusion-weighted MRI. Abdominal Radiology. 44(5). 1756–1765. 22 indexed citations
4.
Radema, Sandra A., et al.. (2019). Neoadjuvant Chemotherapy for Locally Advanced T4 Colon Cancer: A Nationwide Propensity-Score Matched Cohort Analysis. Digestive Surgery. 37(4). 292–301. 42 indexed citations
5.
Angus, Lindsay, C. Willemien Menke‐van der Houven van Oordt, Daniëlle A.M. Heideman, et al.. (2019). RAS and BRAF mutations in cell‐free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue‐tested RAS wild‐type advanced colorectal cancer. Molecular Oncology. 13(11). 2361–2374. 33 indexed citations
6.
7.
Radema, Sandra A., et al.. (2017). Intravenous Lidocaine: Old-School Drug, New Purpose—Reduction of Intractable Pain in Patients with Chemotherapy Induced Peripheral Neuropathy. Pain Research and Management. 2017. 1–9. 33 indexed citations
8.
Kurk, Sophie A., Petra H.M. Peeters, Rebecca K. Stellato, et al.. (2017). Impact of sarcopenia on dose limiting toxicities in metastatic colorectal cancer patients (mCRC pts) receiving palliative systemic treatment. Annals of Oncology. 28. v544–v545. 3 indexed citations
9.
10.
Radema, Sandra A., et al.. (2015). The in vitro mechanisms and in vivo efficacy of intravenous lidocaine on the neuroinflammatory response in acute and chronic pain. European Journal of Pain. 20(5). 655–674. 80 indexed citations
11.
Hugen, Niek, Rob H.A. Verhoeven, Sandra A. Radema, et al.. (2013). Prognosis and value of adjuvant chemotherapy in stage III mucinous colorectal carcinoma. Annals of Oncology. 24(11). 2819–2824. 86 indexed citations
12.
Radema, Sandra A., et al.. (2012). Dysphonia as a Previously Unreported Side Effect of Bevacizumab Treatment in Patients With Metastatic Breast Cancer. Annals of Oncology. 23. ix122–ix122. 1 indexed citations
13.
Beerepoot, Laurens V., Sandra A. Radema, Els O. Witteveen, et al.. (2006). Phase I Clinical Evaluation of Weekly Administration of the Novel Vascular-Targeting Agent, ZD6126, in Patients With Solid Tumors. Journal of Clinical Oncology. 24(10). 1491–1498. 89 indexed citations
14.
Beerepoot, Laurens V., Jeany M. Rademaker-Lakhai, Els O. Witteveen, et al.. (2006). Phase I and pharmacokinetic evaluation of enzastaurin combined with gemcitabine and cisplatin in advanced cancer. Journal of Clinical Oncology. 24(18_suppl). 2046–2046. 9 indexed citations
15.
Rademaker-Lakhai, Jeany M., Els O. Witteveen, Sandra A. Radema, et al.. (2004). Phase I and pharmacologic study of enzastaurin HCl, gemcitabine and cisplatin. Journal of Clinical Oncology. 22(14_suppl). 3129–3129. 7 indexed citations
16.
Stronkhorst, Arnold, Sandra A. Radema, Sandro L. Yong, et al.. (1997). CD4 antibody treatment in patients with active Crohn's disease: a phase 1 dose finding study.. Gut. 40(3). 320–327. 87 indexed citations
17.
Meenan, John, Marcel L.C.M. Mevissen, Houshang Monajemi, et al.. (1996). Mechanisms underlying neutrophil adhesion to apical epithelial membranes.. Gut. 38(2). 201–205. 16 indexed citations
18.
Hommes, Daan W., Sandra A. Radema, J. Jansen, et al.. (1995). Production and cellular source of interleukin-8 in ulcerative colitis. Inflammatory Bowel Diseases. 1(2). 108–116. 8 indexed citations
19.
Radema, Sandra A., et al.. (1995). Anti-CD4 therapy decreases epithelial expression of HLA-DR molecules in patients with Crohn's disease. Inflammatory Bowel Diseases. 1(3). 193–197. 9 indexed citations
20.
Radema, Sandra A., Sander J. H. van Deventer, & Anthony Cerami. (1991). Interleukin 1β is expressed predominantly by enterocytes in experimental colitis. Gastroenterology. 100(5). 1180–1186. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Efstathios Antoniou Breakdown of academic impact, for papers by Christian Klemann Breakdown of academic impact, for papers by Delphine Bonnet Breakdown of academic impact, for papers by Victoria P. Tan Breakdown of academic impact, for papers by Mariana Kiomy Osako Breakdown of academic impact, for papers by K Orita Breakdown of academic impact, for papers by Beat Künzli Breakdown of academic impact, for papers by Ayşe Dursun Breakdown of academic impact, for papers by Yifeng Zou Breakdown of academic impact, for papers by Jee Hyun Kim
Rankless by CCL
2026